Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Dermatologie (Heidelberg, Germany)
|
October 23, 2025
[Primary cutaneous B-cell lymphomas-an overview of established and novel aspects]
Inga Hansen-Abeck, Anne Menz, Stefan W Schneider, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 26, 2024
Mogamulizumab-associated rash - Case series and review of the literature
Inga Hansen, Finn Abeck, Anne Menz, et al.
Reports (MDPI)
|
July 29, 2025
Trophoblast Cell Surface Antigen 2 (Trop2) Is Expressed in Cases of EBV-Positive Diffuse Large B-Cell Lymphoma Emerging from Angioimmunoblastic T-Cell Lymphoma
Susanne Ghandili, Judith Dierlamm, Carsten Bokemeyer, et al.
Travel Medicine and Infectious Disease
|
April 28, 2020
Relapsing cutaneous leishmaniasis in a patient requiring TNF-α-inhibitor Infliximab for Takayasu-arteritis: Case report and review of the literature
Melina Heinemann, Till F Omansen, Annette Hennigs, et al.
The Journal of Dermatology
|
November 18, 2024
Characterization of non-IgA vasculitis: Demographic, clinical, and treatment-related features in a retrospective analysis of 28 biopsy-confirmed cases from a German university hospital
Inga Hansen-Abeck, Alessandra Rünger, Lisa Piepke, et al.
PPAR Research
|
July 30, 2009
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
Stefanie Meyer, Thomas Vogt, Michael Landthaler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 15, 2024
Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanoma
Glenn Geidel, Niousha Parnian, Christian Meß, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 12, 2025
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition
Isabel Heidrich, Charlotte Rautmann, Cedric Ly, et al.
Molecular Carcinogenesis
|
May 4, 2017
Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion
Manuela Juhnke, Asmus Heumann, Viktoria Chirico, et al.
Pathology, Research and Practice
|
July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer
Viktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Dermatologie (Heidelberg, Germany)
|
October 23, 2025
[Primary cutaneous B-cell lymphomas-an overview of established and novel aspects]
Inga Hansen-Abeck, Anne Menz, Stefan W Schneider, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 26, 2024
Mogamulizumab-associated rash - Case series and review of the literature
Inga Hansen, Finn Abeck, Anne Menz, et al.
Reports (MDPI)
|
July 29, 2025
Trophoblast Cell Surface Antigen 2 (Trop2) Is Expressed in Cases of EBV-Positive Diffuse Large B-Cell Lymphoma Emerging from Angioimmunoblastic T-Cell Lymphoma
Susanne Ghandili, Judith Dierlamm, Carsten Bokemeyer, et al.
Travel Medicine and Infectious Disease
|
April 28, 2020
Relapsing cutaneous leishmaniasis in a patient requiring TNF-α-inhibitor Infliximab for Takayasu-arteritis: Case report and review of the literature
Melina Heinemann, Till F Omansen, Annette Hennigs, et al.
The Journal of Dermatology
|
November 18, 2024
Characterization of non-IgA vasculitis: Demographic, clinical, and treatment-related features in a retrospective analysis of 28 biopsy-confirmed cases from a German university hospital
Inga Hansen-Abeck, Alessandra Rünger, Lisa Piepke, et al.
PPAR Research
|
July 30, 2009
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
Stefanie Meyer, Thomas Vogt, Michael Landthaler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 15, 2024
Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanoma
Glenn Geidel, Niousha Parnian, Christian Meß, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 12, 2025
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition
Isabel Heidrich, Charlotte Rautmann, Cedric Ly, et al.
Molecular Carcinogenesis
|
May 4, 2017
Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion
Manuela Juhnke, Asmus Heumann, Viktoria Chirico, et al.
Pathology, Research and Practice
|
July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer
Viktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Page
of 8